0001127602-20-001921.txt : 20200117 0001127602-20-001921.hdr.sgml : 20200117 20200117160851 ACCESSION NUMBER: 0001127602-20-001921 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200115 FILED AS OF DATE: 20200117 DATE AS OF CHANGE: 20200117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Machiels Alec CENTRAL INDEX KEY: 0001496687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 20533656 MAIL ADDRESS: STREET 1: 505 PARK AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-01-15 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001496687 Machiels Alec C/O APELLIS PHARMACEUTICALS, INC 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Common Stock 2020-01-15 4 M 0 2500 2.67 A 672044 D Common Stock 2020-01-15 4 S 0 2500 41.47 D 669544 D Common Stock 930 I Held by spouse Stock Option (Right to Buy) 2.67 2020-01-15 4 M 0 2500 0 D 2023-12-04 Common Stock 2500 185029 D This is a scheduled exercise from 10B5-1 trading plan. This option was granted on December 5, 2013 and fully vested. /s/ David Watson, attorney-in-fact for Alec Machiels 2020-01-16